Skip to main content
HR 2022 115th Congress House Health Administrative law and regulatory procedures Business records Department of Health and Human Services Fraud offenses and financial crimes Hazardous wastes and toxic substances Health information and medical records Infectious and parasitic diseases Licensing and registrations Medical education Medical research Organ and tissue donation and transplantation Product safety and quality

LATTS Act of 2017

Introduced: April 6, 2017 Introduced by: Gosar, Paul A. Republican · Arizona See on congress.gov
Sign in to write a letter Sign in to watch
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Apr 7, 2017
Referred to the Subcommittee on Health.
Apr 6, 2017
Referred to the House Committee on Energy and Commerce.
Apr 6, 2017
Introduced in House
 Plain-English summary Congressional Research Service

Label and Transport Tissues Safely Act of 2017 or the LATTS Act of 2017

This bill prohibits the sale of human tissue for research or education unless the seller has a non-transplant tissue bank license, each package of tissue is labeled with specified information, and each package is wrapped in the prescribed manner.

The Department of Health and Human Services (HHS) shall establish a process for the approval, suspension, and revocation of non-transplant tissue bank licenses.

False labeling of packages of human tissue is prohibited.

HHS or any accrediting body authorized by HHS is allowed to enter and inspect any facility that is subject to a non-transplant tissue bank license.

HHS shall recall any human tissue specimen that is an imminent or substantial hazard to public health.

The bill makes it unlawful to knowingly sell or otherwise transfer any human tissue specimen if the transfer affects interstate commerce.

What's happening now April 7, 2017

Referred to the Subcommittee on Health.

 Committees of jurisdiction 2
 Cosponsors 2
All 2 Republican 2